News

HHS slashes funding for mRNA vaccine development
US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms through the Biomedical Advanced Research and Development Authority, the agency said Tuesday.
What is an mRNA vaccine, and why is it controversial?
Messenger RNA vaccines, or mRNA, differ from traditional ones. Instead of growing a virus and weakening it to allow the body to engage its natural defenses, mRNA vaccines use pieces of genetic code to manufacture a protein, a piece of the virus. That causes the body to create its own antibodies against the virus.
RFK Jr. halts $500 million for mRNA vaccine research
HHS Secretary Robert F. Kennedy Jr. says the federal government is calling off around $500 million worth of vaccine development projects that use mRNA technology.
RFK Jr. Cancels $500M in mRNA Vaccine Research Projects
U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has canceled nearly $500 million in grants and contracts meant to support mRNA vaccine development, the agency announced Tuesday.
RFK Jr.'s reasons for cutting mRNA vaccine not supported by evidence
U.S. Health Secretary Robert F. Kennedy Jr. incorrectly argued mRNA vaccines are ineffective to justify the Department of Health and Human Service's recent decision to cancel $500 million in government-funded research projects to develop new vaccines using the technology.
RFK Jr. cancels nearly $500 million in funds for mRNA vaccine development
Health and Human Services Secretary Robert F. Kennedy Jr. is halting nearly $500 million in funding to develop vaccines using mRNA technology. Dr. Jon LaPook reports.
RFK Jr. pulls funding for mRNA vaccines as scientists pursue breakthrough treatments for HIV, cancer, the flu and more
Health Secretary Robert F. Kennedy Jr. announced Tuesday that the federal government is canceling nearly $500 million in funding for the development of mRNA vaccines, a revolutionary new technology that was first put into widespread use during the COVID-19 pandemic.
RFK Jr. Ordered the HHS to Stop Funding mRNA Vaccine Development. The Edict Hit a Biotech Working on an Unrelated Treatment, Too.
A biotech that lost federal funding Tuesday following Health Secretary Robert F. Kennedy Jr.’s edict that his agency’s pandemic preparedness division stop funding development of messenger RNA-based vaccines says it wasn’t working on mRNA-based vaccines at all.
RFK Jr. Shifts $500 Million From mRNA Research to 'Safer' Vaccines. Does the Data Back That Up?
Secretary of the Department of Health and Human Services Robert F. Kennedy Jr. has launched yet another scientifically unjustified attack on promising vaccine research by canceling mRNA vaccine research contracts sponsored by the Biomedical Advanced Research and Development Authority (BARDA).
RFK Jr Pulls Millions Of Dollars Of mRNA Vaccine Funding, Citing Misinformation – Here's What To Know
The US Department of Health and Human Services (HHS), under the leadership of Robert F. Kennedy Jr., just announced a “coordinated wind-down” of mRNA vaccine development. That includes the termination of 22 research contracts worth hundreds of millions of dollars,
United States: RFK Jr. suspends funding for mRNA vaccines
Robert F. Kennedy Jr., US Secretary of Health and Human Services, announced the cancellation of a $500 million American funding for mRNA vaccines.
Stocktwits on MSN2d
Moderna, Pfizer, Sanofi In Focus As US Winds Down mRNA Vaccine Plans; Retail Turns Bearish On AstraZeneca
Pfizer (PFE), and Sanofi (SNY) drew increased attention on Tuesday as traders reacted to the U.S. government’s move to halt ...
Sanofi to Buy Vaccine Developer Vicebio for Up to $1.6 Billion
The deal seeks to strengthen the drugmaker’s portfolio of respiratory vaccines and help it move on from pipeline setbacks.
Al Jazeera on MSN23h
WHO says US ending mRNA vaccine contracts a ‘significant blow’
The decision by US President Donald Trump’s administration to terminate 22 federal contracts for mRNA-based vaccines is a ...
BioSpace17d
Sanofi Makes $1.6B Vaccine Bet With Vicebio Acquisition
The acquisition, which will give Sanofi a combination vaccine for respiratory syncytial virus and human metapneumovirus, ...
Kennedy to halt $500 million in vaccine projects
Health Secretary Robert F. Kennedy Jr. announced plans Tuesday to cancel $500 million in vaccine development projects. In a ...
HHS phases out mRNA vaccine trials for COVID-19, bird flu
HHS says the elimination of 22 mRNA vaccine development projects for COVID-19 and bird flu signals a shift in vaccine ...
Novavax raises annual revenue forecast on vaccine supply partnerships
Novavax raised its full-year adjusted revenue forecast on Wednesday, banking on higher sales tied to its vaccine supply ...
Sanofi Expands Respiratory Vaccine Portfolio With UK Biotech Buy
Sanofi acquires Vicebio for $1.15 billion, adding a next-gen RSV-hMPV vaccine and ‘Molecular Clamp' tech to strengthen its ...
Stocktwits on MSN2d
Novavax CFO Says Sanofi To Cover Majority Of Future Nuvaxovid Study Costs, Retail Urges Partnership Diversification
Novavax Inc. (NVAX) on Wednesday said that the postmarketing commitment study for its COVID-19 vaccine Nuvaxovid will not ...